Get started
Author

Benlazar Mohamed

OpenAlex ID: A5067540537
Global Access to Multiple Myeloma Therapies
2025 · Rawan Atallah, Yara Shatnawi, et al. · JCO Global Oncology · 6
The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally
2023 · Rawan Atallah, Yara Shatnawi, et al. · Blood · 4
The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally
2024 · Rawan Atallah, Yara Shatnawi, et al. · Transplantation and Cellular Therapy · 3
Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant
2023 · Aytaj Mammadzadeh, Yara Shatnawi, et al. · Blood · 1
CML-337 Therapeutic Results of Second-Generation TKIs in a CML Multicentric Study in the West Region of Algeria
2022 · Siali Nadjat, Benlazar Mohamed · Clinical Lymphoma Myeloma & Leukemia
Poster: CML-337 Therapeutic Results of Second-Generation TKIs in a CML Multicentric Study in the West Region of Algeria
2022 · Siali Nadjat, Benlazar Mohamed · Clinical Lymphoma Myeloma & Leukemia
CML-216 Hypereosinophilia Syndrome With FIP1L1-PDGFRA Transcript Revealed by Cardiac Involvement
2022 · Siali Nadjat, Benlazar Mohamed · Clinical Lymphoma Myeloma & Leukemia
Works count: 7
Citation count: 14
H-index: 3
I10-index:
Year
Topic
Type